A novel de novo SCN1A missense mutation in severe myoclonic epilepsy borderland

Nicola Specchio, Marina Trivisano, Martina Balestri, Elena Gennaro, Luigi M. Specchio, Lucia Fusco, Federico Zara, Federico Vigevano

Research output: Contribution to journalArticlepeer-review


In this report we describe a novel missense SCN1A mutation in a patient affected by Severe Myoclonic Epilepsy Borderland (SMEB). This three and a half yearold female patient experienced prolonged febrile seizures at the age of 14 months, followed by generalized tonicclonic seizures, atonic seizures, atypical absences almost in a cluster and triggered by fever. Cognitive and motor development was normal. The case was suggestive for SMEB. SCN1A analysis revealed an unknown de novo point mutation: a heterozygous replacement of nucleotide G with nucleotide T in position 4183 of the coding region of the gene (c.4183 G>T) in exon 21. This mutation causes the replacement of aspartic acid with tyrosine in 1395 (p.D1396Y). Even if other SCN1A missense mutations localized in the same region are associated to SMEB, a definite genotype-phenotype correlation has not yet been found, probably because other factors are involved in the pathogenesis of this type of epilepsy.

Original languageEnglish
Pages (from-to)281-283
Number of pages3
JournalActa Neurologica Belgica
Issue number3
Publication statusPublished - 2010


  • De novo missense mutation
  • Dravet syndrome
  • Epilepsy
  • Novel SCN1A mutation
  • SMEB
  • SMEI

ASJC Scopus subject areas

  • Clinical Neurology


Dive into the research topics of 'A novel de novo SCN1A missense mutation in severe myoclonic epilepsy borderland'. Together they form a unique fingerprint.

Cite this